Disclosure 0001873905-26-000002-2

SEC FORM 4

$2,539,892.74

Candel Therapeutics, Inc. (CADL)

Sale of 220,866 shares at $11.4997 per share.

Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Candel Therapeutics, Inc. (CADL)." Disclosed 2026-09-11. https://desqlong.com/cards/0001873905-26-000002-2 (retrieved 2026-09-26).